It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
TYSON 2.0’s entry into South Africa aligns seamlessly with Carma HoldCo’s broader mission of leveraging cultural icons to transform industries. This expansion reflects the company’s commitment to ...